Hyperglycosylated analog of erythropoietin with longer half-life due to additional N-linked carbohydrate chains, allowing less frequent dosing. Stimulates erythroid progenitor proliferation and differentiation.
At a glance
Class
Long-Acting Erythropoiesis-Stimulating Agent (ESA)
Storage
Refrigerate 2–8°C; do not freeze or shake; protect from light
Dosing
Preferred over epoetin due to less frequent dosing and potentially lower immunog
Frequency
Weekly to monthly (based on PCV response)
Preferred ESA in cats — lower immunogenicity risk than epoetin alfa
Frequency
Weekly initially, then taper
Educational reference only
This information is provided for educational purposes and is not a substitute for professional veterinary advice, diagnosis, or treatment. Always consult a qualified veterinarian before administering any medication to your pet.
Find a vet near you →Safety
PCV q2 weeks until stable, then monthlyBlood pressureIron statusReticulocyte count
Educational reference only
This information is provided for educational purposes and is not a substitute for professional veterinary advice, diagnosis, or treatment. Always consult a qualified veterinarian before administering any medication to your pet.
Find a vet near you →Interactions
No documented interactions.
FAQs
Frequently asked questions
›What is Darbepoetin Alfa?
Darbepoetin Alfa is a long-acting erythropoiesis-stimulating agent (esa) used in pets. Hyperglycosylated analog of erythropoietin with longer half-life due to additional N-linked carbohydrate chains, allowing less frequent dosing. Stimulates erythroid progenitor proliferation and differentiation.
›What is Darbepoetin Alfa used for in pets?
Darbepoetin Alfa is used in veterinary medicine for: Preferred over epoetin due to less frequent dosing and potentially lower immunog; Preferred ESA in cats — lower immunogenicity risk than epoetin alfa.
›What is the Darbepoetin Alfa dose for dogs?
For dogs, Darbepoetin Alfa is typically dosed as follows — Preferred over epoetin due to less frequent dosing and potentially lower immunog: 0.45–1 mcg/kg SQ Weekly to monthly (based on PCV response). Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
›What is the Darbepoetin Alfa dose for cats?
For cats, Darbepoetin Alfa is typically dosed as follows — Preferred ESA in cats — lower immunogenicity risk than epoetin alfa: 0.45 mcg/kg SQ Weekly initially, then taper. Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
›Does Darbepoetin Alfa need a prescription?
Yes. Darbepoetin Alfa is a prescription medication and should only be administered under veterinary supervision.
Educational reference only
This information is provided for educational purposes and is not a substitute for professional veterinary advice, diagnosis, or treatment. Always consult a qualified veterinarian before administering any medication to your pet.
Find a vet near you →References
References
The PetCare.AI drug reference is built from 13 authoritative sources cited across 580 drug monographs.
Textbooks & handbooks — 5
- Plumb's Veterinary Drug Handbook
- Withrow & MacEwen's Small Animal Clinical Oncology
- Merck Veterinary Manual
- NRC Nutrient Requirements of Dogs and Cats
- Veterinary Pharmacology and Therapeutics (Riviere & Papich)
Clinical guidelines & consensus — 4
- ASPCA Animal Poison Control Center Guidelines
- AAHA Diabetes Management Guidelines
- ASPCA Poison Control Guidelines
- RECOVER CPR Guidelines
Journals & peer-reviewed studies — 2
- EPIC Study (J Vet Intern Med 2016)
- JVIM FAT CAT Study
Regulatory & approvals — 1
- CDSCO Veterinary Drug Approval Registry (1969–2026)
Databases — 1
- Washington State University VCPL MDR1 Database